Global Infectious Disease Molecular Diagnostics Market Analysis By Product(Instruments (Benchtop instruments, Portable instruments), Reagents & Kits, Services, Others), By Technology(Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Isothermal Nucleic Acid Amplification Technology (INAAT), Chips & Microarrays, Mass Spectrometry, Sequencing, Transcription Mediated Amplification (TMA), Others), By Application(Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, HPV, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, Other Infectious Diseases), By End-User(Hospitals, Clinics and Outpatient Diagnostic Centres, Diagnostic Laboratories, Research Institutes) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Oct 2025
 - Report ID: 163576
 - Number of Pages: 393
 - Format:
                                        
 
- 
                                            keyboard_arrow_up
 - 
                                            
 - 
                                            
- F. Hoffmann‑La Roche Ltd. (Roche)
 - Abbott Laboratories
 - Danaher Corporation (including its subsidiary Cepheid)
 - bioMérieux SA
 - Thermo Fisher Scientific Company Profile
 - Siemens Healthineers AG
 - Becton, Dickinson and Company (BD)
 - Hologic Inc.
 - QIAGEN N.V.
 - Grifols S.A.
 - DiaSorin S.p.A.
 - Seegene Inc.
 - Bio‑Rad Laboratories Inc.
 - Quest Diagnostics Incorporated
 
 
Our Clients
✖
        Request a Sample Report
        We'll get back to you as quickly as possible
        
    
            

